Streamline Health® Reports Fourth Quarter Fiscal Year 2012 Financial Results; 49% Increase In Revenue; 11% Increase In Adjusted EBITDA*

Total FY 2012 Revenue and Adjusted EBITDA* Increased 39% and 52% Respectively

Backlog Increased 86% to $51.0 Million

Apr 24, 2013, 09:00 ET from Streamline Health Solutions, Inc.

ATLANTA, April 24, 2013 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of SaaS-based enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers, today announced financial results for the fourth quarter and fiscal year 2012, which ended January 31, 2013.

Revenues for the three-month period ended January 31, 2013, increased 49% to $6,738,000 versus  $4,518,000 in the comparable period of fiscal 2011. The quarterly increase was primarily attributable to   the Company's Collabra suite of coding and CDI solutions acquired as part of the Meta Health Technology, Inc. transaction completed in the third quarter of fiscal year 2012.

"We completed another very solid quarter of performance contributing to a very successful year," said Robert E. Watson, President and Chief Executive Officer of Streamline Health. "We realized many significant accomplishments during the year, all of which were made possible by remaining focused on developing and deploying meaningful solutions for our valued clients. Specifically, during the fourth quarter, revenue and adjusted EBITDA increased substantially; new sales bookings totaled $5.5 million; and maintenance and SaaS contract renewals totaled $2.3 million."

"For the year, revenue increased 39% over fiscal year 2011, and SaaS-based revenue increased 76%.   Adjusted EBITDA improved 52% over last year, and we exited the fiscal year 2012 with our sales backlog up 86% to $51 million."

Highlights for the quarter and the fiscal year ended January 31, 2013 included:

  • Revenue for the fourth quarter and the fiscal year 2012 was $6,738,000 and  $23,767,000 respectively, an increase of 49% and 39% over comparable periods in 2011;
  • Adjusted EBITDA* for fourth quarter and the fiscal year 2012 was $1.7 million and $6.6 million, respectively, an increase of 11% and 52% over comparable periods in 2011;
  • Recorded net loss of $7,807,000 for the three-month period ended  January 31, 2013, of which $5,913,000 was attributed to a loss on conversion of convertible notes and $779,000 attributed to non-recurring transaction related expenses, resulting in an adjusted non-GAAP net loss* of $1,115,000;
  • Recorded net loss of $5,379,000 for the twelve-month period ended  January 31, 2013, of which $5,970,000 was attributed to a loss on conversion of convertible notes and $1,940,000 was attributed to non-recurring transaction-related expenses, resulting in an adjusted non-GAAP net  earnings* of $2,531,000;
  • Software as a Service (SaaS) revenues for fiscal year 2012 increased 76% over 2011;
  • Maintenance and support revenues for the quarter and the year increased $1.1 million and $2.3 million, respectively, over comparable periods in 2011;
  • New sales bookings for the quarter were $5.5 million;
  • Maintenance and SaaS contract renewals for the quarter were $2.3 million;
  • Backlog at the end of the quarter was $51.0 million.

New sales bookings for the fourth quarter increased 83% to $5.5 million, compared to $3.0 million in the fourth quarter of 2011, primarily consisting of professional services and software as a service (SaaS) contracts.  Maintenance and SaaS renewals or extensions were $2.3 million, as compared to $8.9 million in the fourth quarter of 2011. The decrease in renewals is due to the fact that several multi-year renewals were made in 2011.

Backlog at January 31, 2013 increased 86% to $51.0 million compared with $27.4 million at January 31, 2012. The increase in the current backlog reflects significant new SaaS contract signings as well as current clients purchasing additional solutions.

Conference Call Information

The Company will conduct a conference call and web cast to review the results on Wednesday, April 24, 2013 at 11:00 a.m. EDT. Interested parties can access the call by dialing 888-539-3696 and then entering the passcode 3463092. A live webcast will also be available by clicking this link: http://bit.ly/10z7Bp9

A replay of the conference call will be available from Wednesday, April 24, 2013 at 2:00 p.m. EDT to Monday, April 29, 2013 at 2:00 p.m. EDT by dialing 888-203-1112 and entering passcode 3463092.

* Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that these measures provide useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "non-GAAP adjusted net earnings (loss)" as GAAP net earnings (loss), plus losses on conversion of convertible notes, transaction  related expenses, and non-recurring operational costs.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees . A table illustrating this measure is included in this publication.

About Streamline Health Streamline Health Solutions, Inc. (NASDAQ: STRM) is a leading provider of SaaS-based healthcare information technology (HCIT) solutions for hospitals and physician groups with offices in Atlanta, Cincinnati and New York. The company's comprehensive suite of solutions includes: enterprise content management (ECM), business analytics, integrated workflow systems, clinical documentation improvement (CDI), and computer assisted coding (CAC). Across the revenue cycle, these solutions offer healthcare enterprises a flexible, customizable way to communicate between disparate departments and information systems to improve processes, boost productivity, and optimize clinical, administrative and financial performance.  For more information, please visit our website at http://www.streamlinehealth.net.  

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company's products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Company Contact:

Ashley Moore

Director, Marketing

(404)-446-2057

ashley.moore@streamlinehealth.net

Investor Contacts:

Randy Salisbury

Investor Relations

(404)-229-4242

randy.salisbury@streamlinehealth.net

BPC Financial Marketing

John Baldissera

800-368-1217

 

STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended

January 31,

                                                                 Fiscal Year Ended

2013

2012

2012

2011

Revenues:

  Systems sales

$

743,730

$

195,598

$

1,463,225

$

722,195

  Professional services

638,897

661,050

3,792,569

3,369,875

  Maintenance and support

3,413,934

2,309,213

11,211,197

8,867,697

  Software as a service

1,941,692

1,352,301

7,299,812

4,156,441

        Total revenues

6,738,253

4,518,162

23,766,803

17,116,208

Operating expenses:

  Cost of systems sales

810,469

486,009

2,747,230

2,237,899

  Cost of services, maintenance and

    support

2,072,870

1,254,658

6,333,566

4,830,117

  Cost of software as a service

662,194

481,327

2,512,156

1,815,986

  Selling, general and administrative

3,259,675

1,835,016

10,060,469

6,577,101

  Research and development

1,114,448

344,845

2,948,313

1,408,749

        Total operating expenses

7,919,656

4,401,855

24,601,734

16,869,852

Operating income (loss)

(1,181,403)

116,307

(834,931)

246,356

Other income (expense):

  Interest expense

(567,849)

(110,995)

(1,957,010)

(178,524)

  Loss on conversion of convertible notes

(5,913,320)

-

(5,970,002)

-

  Miscellaneous income (expenses)

487,190

11,211

494,677

(30,943)

Earnings (loss) before income taxes

(7,175,382)

16,523

(8,267,266)

36,889

  Income tax benefit (expense)

(631,342)

(12,000)

2,888,537

(24,315)

Net earnings (loss)

$

(7,806,724)

$

4,523

$

(5,378,729)

$

12,574

Less: deemed dividends on Series A Preferred Shares

(36,915)

(176,048)

Net earnings (loss) attributable to common shareholders

$

(7,843,639)

$

(5,554,777)

Basic net earnings (loss) per common share

$

(0.63)

$

0.00

$

(0.48)

$

0.00

Number of shares used in basic per common share computation

12,492,611

9,645,140

11,634,540

9,887,841

Diluted net earnings (loss) per common share

$

(0.63)

$

0.00

$

(0.48)

$

0.00

Number of shares used in diluted per common share computation

12,492,611

9,648,628

11,634,540

9,899,073

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

Assets

January 31,

2013

2012

Current assets:

  Cash and cash equivalents

$

7,500,256

$

2,243,054

  Accounts receivable, net of allowance for doubtful

    accounts of $134,000 and $100,000, respectively

8,685,017

4,484,605

  Contract receivables

1,481,819

430,370

  Prepaid hardware and third party software for future

    delivery

22,777

38,193

  Prepaid client maintenance contracts

1,080,330

788,917

  Other prepaid assets

997,024

256,104

  Deferred income taxes

-

167,000

  Other current assets

110,555

-

        Total current assets

19,877,778

8,408,243

Non-current assets:

Property and equipment:

  Computer equipment

3,420,452

2,892,885

  Computer software

2,196,236

2,131,730

  Office furniture, fixtures and equipment

843,274

756,375

  Leasehold improvements

697,570

667,000

7,157,532

6,447,990

  Accumulated depreciation and amortization

(5,958,727)

(5,232,321)

Property and equipment, net

1,198,805

1,215,669

 Contract receivables, less current portion

126,626

221,596

 Capitalized software development costs, net of

   accumulated amortization of $17,464,601 and

   $14,805,236, respectively

12,816,486

9,830,175

Intangible assets, net

8,188,131

417,666

Deferred financing costs, net

541,740

145,857

Goodwill

12,133,304

4,060,504

 Other, including deferred taxes of $0 and $711,000,

   respectively

383,708

841,348

       Total non-current assets

35,388,800

16,732,815

$

55,266,578

$

25,141,058

 

STREAMLINE HEALTH SOLUTIONS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS

 

Liabilities and Stockholders' Equity

January 31,

2013

2012

Current liabilities:

  Accounts payable

$

1,495,913

$

879,027

  Accrued compensation

2,088,850

887,130

  Accrued other expenses

1,325,039

479,526

  Deferred revenues

9,810,442

6,496,938

  Contingent consideration for earn-out

1,319,559

-

  Current portion of long-term debt

1,250,000

-

  Current portion of deferred tax liability

35,619

-

    Total current liabilities

17,325,422

8,742,621

Non-current liabilities:

  Term loans, less current portion

12,437,501

4,120,000

  Convertible note

-

3,000,000

  Warrants liability

3,649,349

-

  Lease incentive liability, less current portion

99,579

47,193

  Contingent consideration for earn-out, less current portion

-

1,232,720

  Deferred income tax liability, less current portion

529,709

-

    Total non-current liabilities

16,716,138

8,399,913

    Total liabilities

34,041,560

17,142,534

Series A 0% Convertible Redeemable Preferred Stock, $.01 par

  value per share, $11,999,985 redemption value, 4,000,000

  shares authorized, 3,999,995 issued and outstanding, net of

  unamortized preferred stock discount of $4,234,269

7,765,716

-

Stockholders' equity:

  Common stock, $.01 par value per share, 25,000,000 shares

    authorized, 12,643,620 and 10,433,716 shares issued and

    outstanding, respectively

126,436

104,338

  Convertible redeemable preferred stock, $.01 par value per

    share, 1,000,000 shares authorized, no shares issued

-

-

Additional paid in capital

49,178,389

38,360,980

Accumulated deficit

(35,845,523)

(30,466,794)

    Total stockholders' equity

13,459,302

7,998,524

$

55,266,578

$

25,141,058

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Twelve Months Ended January 31,

2013

2012

Operating activities:

  Net earnings (loss)

$

(5,378,729)

$

12,574

  Adjustments to reconcile net earnings (loss) to net cash

    provided by (used in) operating activities, net of effect of acquisitions:

    Depreciation

726,406

727,794

    Amortization of capitalized software development costs

2,659,365

1,972,889

    Amortization of intangible assets

583,535

2,334

    Amortization of other deferred costs

241,478

11,643

    Amortization of debt discount

111,583

-

    Valuation adjustment for warrants liability

(489,434)

-

    Deferred tax benefit

(2,999,284)

-

    Valuation adjustment for contingent earn-out

86,839

-

    Net loss from conversion of convertible notes

5,970,002

-

    Loss on disposal of fixed assets

-

26,667

    Share-based compensation expense

956,144

894,800

    Provision for accounts receivable

67,464

159,000

  Changes in assets and liabilities, net of assets acquired:

    Accounts and contract receivables

(2,923,242)

(1,485,634)

    Other assets

(1,129,255)

(47,081)

    Accounts payable

526,149

202,395

    Accrued expenses

1,056,047

(311,449)

    Deferred revenues

(180,200)

730,143

  Net cash provided by (used in) operating activities

(115,132)

2,896,075

Investing activities:

  Purchases of property and equipment

(576,736)

(408,064)

  Capitalization of software development costs

(1,999,676)

(2,600,000)

  Payment for acquisition

(12,161,614)

(2,124,479)

  Net cash used in investing activities

(14,738,026)

(5,132,543)

Financing activities:

  Proceeds from term loans

9,880,000

4,120,000

  Principal repayments on term loans

(312,500)

-

  Proceeds from private placement

12,000,000

-

  Payment of deferred financing costs

(1,271,862)

(157,500)

  Net change under revolving credit facility

-

(1,200,000)

  Proceeds from exercise of stock options and stock purchase plan

282,628

92,722

  Proceeds from stock sale

-

403,988

  Payment of success fee

(467,906)

-

  Payments on capital lease

-

(183,637)

  Net cash provided by financing activities

20,110,360

3,075,573

Increase in cash and cash equivalents

5,257,202

839,105

Cash and cash equivalents at beginning of year

2,243,054

1,403,949

Cash and cash equivalents at end of year

$

7,500,256

$

2,243,054

Supplemental cash flow disclosures:

  Interest paid

$

1,626,750

$

92,431

  Income taxes paid

$

84,990

$

20,136

Supplemental disclosure of non-cash financing activities:

Convertible note payable issued in conjunction with acquisition

$

-

$

3,000,000

Conversion of $3,000,000 note payable, Interpoint to common shares

3,116,182

-

Issuance of 393,086 shares of common stock, as part of Meta purchase price

1,501,609

-

Deemed dividends on Series A Preferred Stock

176,048

-

Issuance of warrants to placement agents

753,737

-

Reclassification of warrants from equity to warrants liability

4,138,783

-

Conversion of notes issued in conjunction with the private placement to Series A Preferred Stock, at fair value

9,182,562

-

 

STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A

Backlog

January 31, 2013

October 31, 2012

January 31, 2012

Streamline Health Software Licenses

$

3,416,000

$

3,650,000

$

181,000

Hardware and Third Party Software

100,000

84,000

194,000

Professional Services

4,527,000

4,348,000

5,945,000

Software as a Service

20,439,000

19,117,000

10,542,000

Maintenance and Support

22,504,000

21,535,000

10,504,000

    Total

$

50,986,000

$

48,734,000

$

27,366,000

 

STREAMLINE HEALTH SOLUTIONS, INC.

New Bookings

(Unaudited)

Table B

New bookings (1)

Three Months Ended

January 31, 2013

Value

% of Total

Bookings

Streamline Health Software licenses

$

555,000

10%

Software as a Service

2,930,000

54%

Maintenance and Support

771,000

14%

Professional Services

1,138,000

21%

Hardware & Third Party Software

73,000

1%

    Total Bookings

$

5,467,000

100%

 

Twelve Months Ended

January 31, 2013

Value

% of Total

Bookings

Streamline Health Software licenses

$

709,000

4%

Software as a Service

13,150,000

70%

Maintenance and Support

947,000

5%

Professional Services

3,612,000

19%

Hardware & Third Party Software

324,000

2%

    Total Bookings

$

18,742,000

100%

 

(1)

Bookings are the aggregate of signed contracts and/or completed customer purchase orders approved and accepted by the Company as binding commitments to purchase its products and/or services. New bookings do not include maintenance services as these tend to be recurring in nature on an annual or more frequent basis.

Reconciliation of Non-GAAP Financial Measures (Unaudited) Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.

 

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

Adjusted EBITDA Reconciliation

Three Months Ended,

Twelve Months Ended,

January 31, 2013

January 31, 2012

January 31, 2013

January 31, 2012

Net earnings (loss)

$

(7,807)

$

5

$

(5,379)

$

13

    Interest expense

568

111

1,957

179

    Income tax expense (benefit) 

632

12

(2,888)

24

    Depreciation

179

189

726

728

     Amortization of capitalized software  development   costs

728

504

2,659

1,973

    Amortization of intangible assets

314

2

584

2

    Amortization of other costs

35

11

35

11

EBITDA

(5,351)

834

(2,306)

2,930

    Share-based compensation expense

312

366

956

895

    Loss on conversion of convertible notes

5,913

-

5,970

-

Transaction related professional fees, advisory fees and other internal direct costs

-

195

796

195

Associate severances and other costs relating to transactions or corporate restructuring

588

100

866

307

    Other non-recurring operating expenses

191

-

278

-

Adjusted EBITDA

$

1,653

$

1,495

$

6,560

$

4,327

Adjusted EBITDA per diluted share

Earnings (loss) per share - diluted

$

(0.63)

$

0.00

$

(0.48)

$

0.00

Adjusted EBITDA per adjusted diluted share (1)

$

0.09

$

0.16

$

0.46

$

0.44

Diluted weighted average shares

12,492,611

9,645,000

11,634,540

9,899,073

    Includable incremental shares – adjusted EBITDA (2)

5,090,421

-

494,109

-

Adjusted diluted shares

17,583,032

9,645,000

12,128,649

9,899,073

(1)

Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.

(2)

The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

 

SOURCE Streamline Health Solutions, Inc.



RELATED LINKS

http://www.streamlinehealth.net